961.13(1m)(c)
(c) Lacks accepted safety for use in treatment under medical supervision.
961.13(2m)
(2m) The controlled substances board may add a substance to schedule I without making the findings required under
sub. (1m) if the substance is controlled under schedule I of
21 USC 812 (c) by a federal agency as the result of an international treaty, convention or protocol.
961.13 History
History: 1971 c. 219;
1995 a. 448 ss.
155,
156,
471; Stats. 1995 s. 961.13.
961.14
961.14
Schedule I. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule I:
961.14(2)
(2) Synthetic opiates. Any material, compound, mixture or preparation which contains any quantity of any of the following synthetic opiates, including any of their isomers, esters, ethers, esters and ethers of isomers, salts and salts of isomers, esters, ethers and esters and ethers of isomers that are theoretically possible within the specific chemical designation:
961.14(2)(a)
(a) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2- phenylethyl)-4-piperidinyl]-N-phenylacetamide);
961.14(2)(b)
(b) Alphacetylmethadol (except levo-alphacetylmethadol (LAAM));
961.14(2)(cd)
(cd) Alpha-methylfentanyl (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);
961.14(2)(cg)
(cg) Alpha-methylthiofentanyl (N-{1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
961.14(2)(dg)
(dg) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);
961.14(2)(er)
(er) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy- 2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
961.14(2)(qs)
(qs) 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4- piperidinyl]-N-phenylpropanamide);
961.14(2)(rg)
(rg) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
961.14(2)(rj)
(rj) 3-methylthiofentanyl (N-{3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
961.14(2)(tg)
(tg) Para-fluorofentanyl (N-[1-(2-phenylethyl)-4-piperidinyl]-N-(4-fluorophenyl)propanamide);
961.14(2)(vg)
(vg) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);
961.14(2)(xm)
(xm) Thiofentanyl (N-{1-[2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
961.14(3)
(3) Substances derived from opium. Any material, compound, mixture or preparation which contains any quantity of any of the following substances derived from opium, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(4)
(4) Hallucinogenic substances. Any material, compound, mixture or preparation which contains any quantity of any of the following hallucinogenic substances, including any of their salts, isomers, precursors, analogs, esters, ethers, and salts of isomers, esters, or ethers that are theoretically possible within the specific chemical designation, in any form contained in a plant, obtained from a plant, or chemically synthesized:
961.14(4)(a)
(a) 3,4-methylenedioxyamphetamine, commonly known as "MDA";
961.14(4)(ag)
(ag) 3,4-methylenedioxyethylamphetamine, commonly known as "MDE";
961.14(4)(am)
(am) 3,4-methylenedioxymethamphetamine, commonly known as "MDMA";
